Without a vaccine, eliminating HCV will be a huge challenge
The experts from the European Liver Patients Association (ELPA) Hep-CORE advisory group provide a great window on the diversity of hepatitis activity and… Read more »
Jeffrey V. Lazarus
Prof Jeffrey V. Lazarus is on the faculty at the Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona and at CHIP, the Centre for Health and Infectious Disease Research and WHO Collaborating Centre on HIV and Viral Hepatitis at Rigshospitalet, the University of Copenhagen. He also serves as the Board Chair of AFEW International, a Board member of the EASL International Liver Foundation, a steering committee member of the HIV in Europe Initiative, the ACHIEVE Hepatitis Elimination coalition and of the European Commission’s joint action on HIV and hepatitis. He is a member of the BMC Editorial Advisory Group.
Latest posts by Jeffrey V. Lazarus (see all)
- The challenge of sustainable funding – Jurgita Poškevičiūtė on financing harm reduction in Lithuania - 7th March 2018
- Unlocking state money for harm reduction – Darko Antik on helping NGOs in Macedonia - 23rd February 2018
- Securing crucial funding for harm reduction in a challenging setting: Iva Jovović discusses LET, the quality-of-life improvement NGO in Croatia - 18th October 2017
Hepatitis: the International Liver Congress nine years on
Jeffrey Lazarus talks here about the changes he has seen in the hepatitis field since the International Liver Congress in 2007.
The task now is identifying people who don’t know they’re infected and connecting them to care
The experts from the European Liver Patients Association (ELPA) Hep-CORE advisory group provide a great window on the diversity of hepatitis activity and… Read more »
Let’s not forget ‘prevention as prevention’
The experts from the European Liver Patients Association (ELPA) Hep-CORE advisory group provide a great window on the diversity of hepatitis activity and… Read more »
We can eliminate hepatitis C – but not without a plan
With the recent introduction of highly effective medicines, the world has made impressive strides toward eliminating the hepatitis C virus (HCV) - a disease… Read more »
Viral hepatitis testing: time to innovate – and deliver!
In this guest blog, Jeffrey Lazarus reflects on the viral hepatitis testing innovation contest that is currently underway.
Building patient groups for viral hepatitis – a new online resource for healthcare professionals
In this guest blog, Jeffrey Lazarus talks about the importance of patient groups for viral hepatitis and introduces a new tool launched by the World Hepatitis… Read more »
Hepatitis and the Sustainable Development Goals: time for an end run
Here, Jeffrey Lazarus talks about the need for a global goal of eliminating viral hepatitis.
What does it mean to ‘eliminate’ viral hepatitis?
As the World Hepatitis Summit draws to a close today, Jeffrey V. Lazarus reflects on how the term 'eliminate' is currently understood in the field of viral… Read more »
The World Hepatitis Summit 2015: an unprecedented global health event
The World Hepatitis Summit kicks off in Scotland today. Jeffrey V. Lazarus, Editor-in-Chief of Hepatology, Medicine and Policy, reflects on this landmark… Read more »